Serum uric acid levels are associated with polymorphisms in the SLC2A9, SF1, and GCKR genes in a Chinese population

Acta Pharmacologica Sinica

Volumn 35, Issue 11, 2014, Pages 1421-1427

  Sun, Xue ^a   Jiang, Feng ^a   Zhang, Rong ^a   Tang, Shan Shan ^a   Chen, Miao ^a   Peng, Dan Feng ^a   Yan, Jing ^a   Wang, Tao ^a   Wang, Shi Yun ^a   Bao, Yu Qian ^a   Hu, Cheng ^a   Jia, Wei Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Chinese; GCKR; genome wide association; gout; SF1; single nucleotide polymorphisms; SLC2A9; uric acid

Indexed keywords

ORGANIC ANION TRANSPORTER 4; SODIUM PHOSPHATE COTRANSPORTER 1; URATE TRANSPORTER; URIC ACID; DNA BINDING PROTEIN; GCKR PROTEIN, HUMAN; GLUCOSE TRANSPORTER; SF1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SLC2A9 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; BODY MASS; CHINESE; CLINICAL ARTICLE; DNA POLYMORPHISM; FEMALE; GCKR GENE; GENDER; GENE; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENOTYPE; GOUT; HUMAN; MALE; META ANALYSIS (TOPIC); METABOLISM; POPULATION; SEX DIFFERENCE; SF1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC2A9 GENE; URIC ACID BLOOD LEVEL; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; GENE FREQUENCY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; META ANALYSIS; MIDDLE AGED; PHENOTYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; TRANSCRIPTION FACTORS; URIC ACID;

EID: 84908448081     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2014.87     Document Type: Article

References (38)

1. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404-10.
2. Jermendy G, Horvath T, Littvay L, Steinbach R, Jermendy AL, Tarnoki AD, et al. Effect of genetic and environmental influences on cardiometabolic risk factors: a twin study. Cardiovasc Diabetol 2011; 10: 96.
3. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 2013; 62: 3307-15.
4. Dai X, Yuan J, Yao P, Yang B, Gui L, Zhang X, et al. Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population. Eur J Epidemiol 2013; 28: 669-76.
5. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005; 25: 1038-44.
6. Bonakdaran S, Kharaqani B. Association of serum uric Acid and metabolic syndrome in type 2 diabetes. Curr Diabetes Rev 2014; 10: 113-7.
7. Haj Mouhamed D, Ezzaher A, Neffati F, Douki W, Gaha L, Najjar MF. Effect of cigarette smoking on plasma uric acid concentrations. Environ Health Prev Med 2011; 16: 307-12.
8. Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ. Uric acid, evolution and primitive cultures. Seminars Nephrol 2005; 25: 3-8.
9. Brandstatter A, Kiechl S, Kollerits B, Hunt SC, Heid IM, Coassin S, et al. Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care 2008; 31: 1662-7.
10. Cirillo P, Sato W, Reungjui S, Heinig M, Gersch M, Sautin Y, et al. Uric acid, the metabolic syndrome, and renal disease. Journal of the American Society of Nephrology : JASN 2006; 17 (12 Suppl 3): S165-8.
11. Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleveland Clin J Med 2006; 73: 1059-64.
12. Nath SD, Voruganti VS, Arar NH, Thameem F, Lopez-Alvarenga JC, Bauer R, et al. Genome scan for determinants of serum uric acid variability. J Am Soc Nephrol 2007; 18: 3156-63.
13. He YY, Zhang R, Shao XY, Hu C, Wang CR, Lu JX, et al. Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients. Acta Pharmacol Sin 2008; 29: 983-9.
14. Qin W, Zhang R, Hu C, Wang CR, Lu JY, Yu WH, et al. A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese. Acta Pharmacol Sin 2010; 31: 450-4.
15. Doring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, et al. SLC2A9 influences uric acid concentrations with pronounced sexspecific effects. Nat Genet 2008; 40: 430-6.
16. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008; 40: 437-42.
17. Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008; 372: 1953-61.
18. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, et al. Metaanalysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009; 5: e1000504.
19. Yang Q, Kottgen A, Dehghan A, Smith AV, Glazer NL, Chen MH, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 2010; 3: 523-30.
20. Karns R, Zhang G, Sun G, Rao Indugula S, Cheng H, Havas-Augustin D, et al. Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia. Ann Hum Genet 2012; 76: 121-7.
21. Okada Y, Sim X, Go MJ, Wu JY, Gu D, Takeuchi F, et al. Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. Nat Genet 2012; 44: 904-9.
22. Kamatani Y, Matsuda K, Okada Y, Kubo M, Hosono N, Daigo Y, et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet 2010; 42: 210-5.
23. Yang B, Mo Z, Wu C, Yang H, Yang X, He Y, et al. A genome-wide association study identifies common variants influencing serum uric acid concentrations in a Chinese population. BMC Med Genomics 2014; 7: 10.
24. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and populationbased linkage analyses. Am J Human Genet 2007; 81: 559-75.
25. Anton FM, Garcia Puig J, Ramos T, Gonzalez P, Ordas J. Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metabolism 1986; 35: 343-8.
26. Zoccolella S, Tortorella C, Iaffaldano P, Direnzo V, D'Onghia M, Luciannatelli E, et al. Low serum urate levels are associated to female gender in multiple sclerosis patients. PloS One 2012; 7: e40608.
27. Akizuki S. Serum uric acid levels among thirty-four thousand people in Japan. Ann Rheum Diseases 1982; 41: 272-4.
28. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, Falchi M, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Human Genet 2008; 82: 139-49.
29. Li S, Sanna S, Maschio A, Busonero F, Usala G, Mulas A, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 2007; 3: e194.
30. Stark K, Reinhard W, Neureuther K, Wiedmann S, Sedlacek K, Baessler A, et al. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large casecontrol study. PloS One 2008; 3: e1948.
31. Tin A, Woodward OM, Kao WH, Liu CT, Lu X, Nalls MA, et al. Genomewide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Human Mol Genet 2011; 20: 4056-68.
32. Sparso T, Andersen G, Nielsen T, Burgdorf KS, Gjesing AP, Nielsen AL, et al. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia 2008; 51: 70-5.
33. Diabetes Genetics Initiative of Broad Institute of H, Mit LU, Novartis Institutes of BioMedical R, Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (New York, NY) 2007; 316: 1331-6.
34. Vaxillaire M, Cavalcanti-Proenca C, Dechaume A, Tichet J, Marre M, Balkau B, et al. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes 2008; 57: 2253-7.
35. Orho-Melander M, Melander O, Guiducci C, Perez-Martinez P, Corella D, Roos C, et al. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 2008; 57: 3112-21.
36. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Int Med 2001; 134: 629-36.
37. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-9.
38. Iseki K, Ikemiya Y, Fukiyama K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int 1997; 51: 850-4.